Treatment.com International (TSE:TRUE) has released an update.
Restart Life Sciences Corp, a Canadian life sciences company, has successfully completed a debt settlement transaction, exchanging over 6.3 million common shares to settle approximately CDN$318,000 in debt. This transaction includes a related party component, where shares were issued to settle debts owed for unpaid fees and loans.
For further insights into TSE:TRUE stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Verizon (NYSE:VZ) Suffers Massive Outage
- Shopify (TSE:SHOP) Surges After Earnings, Holiday Projections
- Baidu Fortifies AI Suite with Two New Tools
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
